Skip to main content

Advertisement

Log in

Functional characterization of common protein variants in the efflux transporter ABCC11 and identification of T546M as functionally damaging variant

  • Original Article
  • Published:
The Pharmacogenomics Journal Submit manuscript

Abstract

Multidrug resistance protein 8 (ABCC11) is an efflux transporter for anionic lipophilic compounds, conferring resistance to antiviral and anticancer agents like 5-fluorouracil (5-FU). ABCC11 missense variants may contribute to variability in drug response but functional consequences, except for the ‘earwax variant’ c.538G>A, are unknown. Using the ‘Screen and Insert’ technology, we generated human embryonic kidney 293 cells stably expressing ABCC11 missense variants frequently occurring in different ethnic populations: c.57G>A, c.538G>A, c.950C>A, c.1637C>T, c.1942G>A, c.4032A>G. A series of in silico prediction analyses and in vitro plasma membrane vesicle uptake, immunoblotting and immunolocalization experiments were undertaken to investigate functional consequences. We identified c.1637C>T (T546M), previously associated with 5-FU-related toxicity, as a novel functionally damaging ABCC11 variant exhibiting markedly reduced transport function of 5-FdUMP, the active cytotoxic metabolite of 5-FU. Detailed analysis of 14 subpopulations revealed highest allele frequencies of c.1637C>T in Europeans and Americans (up to 11%) compared with Africans and Asians (up to 3%).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Meyer UA, Zanger UM, Schwab M . Omics and Drug Response. Annu Rev Pharmacol Toxicol 2013; 53: 475–502.

    Article  CAS  PubMed  Google Scholar 

  2. Wang L, McLeod HL, Weinshilboum RM . Genomics and drug response. N Engl J Med 2011; 364: 1144–1153.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X et al. Membrane transporters in drug development. Nat Rev Drug Discov 2010; 9: 215–236.

    Article  CAS  PubMed  Google Scholar 

  4. Schuetz JD, Swaan PW, Tweedie DJ . The role of transporters in toxicity and disease. Drug Metab Dispos 2014; 42: 541–545.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Errasti-Murugarren E, Pastor-Anglada M . Drug transporter pharmacogenetics in nucleoside-based therapies. Pharmacogenomics 2010; 11: 809–841.

    Article  CAS  Google Scholar 

  6. Slot AJ, Molinski SV, Cole SP . Mammalian multidrug-resistance proteins (MRPs). Essays Biochem 2011; 50: 179–207.

    Article  CAS  PubMed  Google Scholar 

  7. Nies AT, Lang T . Multidrug resistance proteins of the ABCC subfamily. In: You G, Morris ME (eds). Drug Transporters: Molecular Characterization and Role in Drug Disposition, 2 edn. John Wiley & Sons: Hoboken, 2014, pp 161–185.

    Google Scholar 

  8. Guo Y, Kotova E, Chen ZS, Lee K, Hopper-Borge E, Belinsky MG et al. MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethoxyethyl)adenine. J Biol Chem 2003; 278: 29509–29514.

    Article  CAS  PubMed  Google Scholar 

  9. Toyoda Y, Ishikawa T . Pharmacogenomics of human ABC transporter ABCC11 (MRP8): potential risk of breast cancer and chemotherapy failure. Anticancer Agents Med Chem 2010; 10: 617–624.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Chen ZS, Guo Y, Belinsky MG, Kotova E, Kruh GD . Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11). Mol Pharmacol 2005; 67: 545–557.

    Article  CAS  PubMed  Google Scholar 

  11. Bortfeld M, Rius M, König J, Herold-Mende C, Nies AT, Keppler D . Human multidrug resistance protein ABCC11 (MRP8), an apical efflux pump for steroid sulfates, is an axonal protein of the central and peripheral nervous system. Neuroscience 2006; 137: 1247–1257.

    Article  CAS  PubMed  Google Scholar 

  12. Baumann T, Bergmann S, Schmidt-Rose T, Max H, Martin A, Enthaler B et al. Glutathione-conjugated sulfanylalkanols are substrates for ABCC11 and gamma-glutamyl transferase 1: a potential new pathway for the formation of odorant precursors in the apocrine sweat gland. Exp Dermatol 2014; 23: 247–252.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Bera TK, Lee S, Salvatore G, Lee B, Pastan I . MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer. Mol Med 2001; 7: 509–516.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Tammur J, Prades C, Arnould I, Rzhetsky A, Hutchinson A, Adachi M et al. Two new genes from the human ATP-binding cassette transporter superfamily, ABCC11 and ABCC12, tandemly duplicated on chromosome 16q12. Gene 2001; 273: 89–96.

    Article  CAS  PubMed  Google Scholar 

  15. Yabuuchi H, Shimizu H, Takayanagi S, Ishikawa T . Multiple splicing variants of two new human ATP-binding cassette transporters, ABCC11 and ABCC12. Biochem Biophys Res Commun 2001; 288: 933–939.

    Article  CAS  PubMed  Google Scholar 

  16. Matsson P, Yee SW, Markova S, Morrissey K, Jenkins G, Xuan J et al. Discovery of regulatory elements in human ATP-binding cassette transporters through expression quantitative trait mapping. Pharmacogenomics J 2012; 12: 214–226.

    Article  CAS  PubMed  Google Scholar 

  17. Toyoda Y, Sakurai A, Mitani Y, Nakashima M, Yoshiura K, Nakagawa H et al. Earwax, osmidrosis, and breast cancer: why does one SNP (538G>A) in the human ABC transporter ABCC11 gene determine earwax type? FASEB J 2009; 23: 2001–2013.

    Article  CAS  PubMed  Google Scholar 

  18. Yoshiura K, Kinoshita A, Ishida T, Ninokata A, Ishikawa T, Kaname T et al. A SNP in the ABCC11 gene is the determinant of human earwax type. Nat Genet 2006; 38: 324–330.

    Article  CAS  PubMed  Google Scholar 

  19. Ishikawa T, Toyoda Y, Yoshiura K, Niikawa N . Pharmacogenetics of human ABC transporter ABCC11: new insights into apocrine gland growth and metabolite secretion. Front Genet 2013; 3: 306.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Magdy T, Arlanov R, Winter S, Lang T, Klein K, Toyoda Y et al. ABCC11/MRP8 polymorphisms affect 5-fluorouracil-induced severe toxicity and hepatic expression. Pharmacogenomics 2013; 14: 1433–1448.

    Article  CAS  PubMed  Google Scholar 

  21. Shimizu H, Taniguchi H, Hippo Y, Hayashizaki Y, Aburatani H, Ishikawa T . Characterization of the mouse Abcc12 gene and its transcript encoding an ATP-binding cassette transporter, an orthologue of human ABCC12. Gene 2003; 310: 17–28.

    Article  CAS  PubMed  Google Scholar 

  22. Arlanov R, Porter A, Strand D, Brough R, Karpova D, Kerb R et al. Functional characterization of protein variants of the human multidrug transporter ABCC2 by a novel targeted expression system in fibrosarcoma cells. Hum Mutat 2012; 33: 750–762.

    Article  CAS  PubMed  Google Scholar 

  23. Keppler D, Jedlitschky G, Leier I . Transport function and substrate specificity of multidrug resistance protein. Methods Enzymol 1998; 292: 607–616.

    Article  CAS  PubMed  Google Scholar 

  24. Keitel V, Kartenbeck J, Nies AT, Spring H, Brom M, Keppler D . Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome. Hepatology 2000; 32: 1317–1328.

    Article  CAS  PubMed  Google Scholar 

  25. Rädisch S, Dickens D, Lang T, Bonnett L, Arlanov R, Johnson MR et al. A comprehensive functional and clinical analysis of ABCC2 and its impact on treatment response to carbamazepine. Pharmacogenomics J 2014; 14: 481–487.

    Article  PubMed  Google Scholar 

  26. Linton KJ, Higgins CF . Structure and function of ABC transporters: the ATP switch provides flexible control. Pflugers Arch 2007; 453: 555–567.

    Article  CAS  PubMed  Google Scholar 

  27. Sarkadi B, Price EM, Boucher RC, Germann UA, Scarborough GA . Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J Biol Chem 1992; 267: 4854–4858.

    CAS  PubMed  Google Scholar 

  28. Ramsey LB, Bruun GH, Yang W, Trevino LR, Vattathil S, Scheet P et al. Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition. Genome Res 2012; 22: 1–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Nies AT, Niemi M, Burk O, Winter S, Zanger UM, Stieger B et al. Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1. Genome Med 2013; 5: 1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Nies AT, Magdy T, Schwab M, Zanger UM . Role of ABC transporters in fluoropyrimidine-based chemotherapy response. Adv Cancer Res 2015; 125: 217–243.

    Article  PubMed  Google Scholar 

  31. Reid G, Wielinga P, Zelcer N, van der Heijden I, Kuil A, de Haas M et al. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci USA 2003; 100: 9244–9249.

    Article  CAS  PubMed  Google Scholar 

  32. Gao M, Cui HR, Loe DW, Grant CE, Almquist KC, Cole SP et al. Comparison of the functional characteristics of the nucleotide binding domains of multidrug resistance protein 1. J Biol Chem 2000; 275: 13098–13108.

    Article  CAS  PubMed  Google Scholar 

  33. Radloff R, Gras A, Zanger UM, Masquelier C, Arumugam K, Karasi JC et al. Novel CYP2B6 enzyme variants in a Rwandese population: functional characterization and assessment of in silico prediction tools. Hum Mutat 2013; 34: 725–734.

    Article  CAS  PubMed  Google Scholar 

  34. Oguri T, Bessho Y, Achiwa H, Ozasa H, Maeno K, Maeda H et al. MRP8/ABCC11 directly confers resistance to 5-fluorouracil. Mol Cancer Ther 2007; 6: 122–127.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We gratefully acknowledge Sabine Rekersbrink and Silvia Hübner for expert technical assistance. RA, TL, ES, MS and ATN were supported by the Robert Bosch Stiftung, Stuttgart, Germany, RA and TL were supported by the German Research Foundation DFG (LA 2406/2-1). GJ was supported by the German Research Foundation DFG (JE 234/4-1). ATN and MS were supported by the 7FP EU Initial Training Network program‚ FightingDrugFailure’ (GA-2009–238132). MS and ES were supported in part by the Federal Ministry for Education and Research (BMBF, Berlin, Germany; grant 03 IS 2061C and 0315755).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Schwab.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the The Pharmacogenomics Journal website

Supplementary information

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arlanov, R., Lang, T., Jedlitschky, G. et al. Functional characterization of common protein variants in the efflux transporter ABCC11 and identification of T546M as functionally damaging variant. Pharmacogenomics J 16, 193–201 (2016). https://doi.org/10.1038/tpj.2015.27

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/tpj.2015.27

  • Springer Nature Limited

This article is cited by

Navigation